SUN PHARMACEUTICAL INDUSTRIES
Back to Income Statement
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹48,497 Cr | ₹43,886 Cr | ₹38,654 Cr | ₹33,498 Cr | ₹32,838 Cr |
What is the latest Revenue of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹48,497 Cr |
| Mar2024 | ₹43,886 Cr |
| Mar2023 | ₹38,654 Cr |
| Mar2022 | ₹33,498 Cr |
| Mar2021 | ₹32,838 Cr |
How is Revenue of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹48,497 Cr | 10.51 | |
| Mar2024 | ₹43,886 Cr | 13.53 | |
| Mar2023 | ₹38,654 Cr | 15.39 | |
| Mar2022 | ₹33,498 Cr | 2.01 | |
| Mar2021 | ₹32,838 Cr | - | |
Compare Revenue of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹416,878.4 Cr | -0.5% | -1.9% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,442.0 Cr | 1.8% | 1.3% | 10.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,770.0 Cr | 2% | 2.4% | 11.2% | Stock Analytics | |
| CIPLA | ₹120,871.0 Cr | -0.2% | -0.7% | 1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,693.0 Cr | -1% | 2.5% | -4.4% | Stock Analytics | |
| MANKIND PHARMA | ₹90,579.8 Cr | 2.4% | -2.2% | -20.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | -0.5% |
-1.9% |
-3% |
| SENSEX | 1% |
0.6% |
7.8% |
You may also like the below Video Courses